Cleared Traditional

K861983 - SUTTER LESSER METATARSAL CAP

K861983 is an FDA 510(k) clearance for SUTTER LESSER METATARSAL CAP, manufactured by Sutter Biomedical, Inc.. The device is a Class 2 Orthopedic device with product code KWD cleared through the Traditional 510(k) pathway after a 109-day FDA review.

K861983 · Sutter Biomedical, Inc. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1986
Decision
109d
Days
Class 2
Risk

K861983 is an FDA 510(k) clearance for the SUTTER LESSER METATARSAL CAP. Classified as Prosthesis, Toe, Hemi-, Phalangeal (product code KWD), Class II - Special Controls.

Submitted by Sutter Biomedical, Inc. (San Diego, US). The FDA issued a Cleared decision on September 8, 1986 after a review of 109 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3730 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Sutter Biomedical, Inc. devices

FDA 510(k) Submission Details - K861983

510(k) Number K861983 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 22, 1986
Decision Date September 08, 1986
Days to Decision 109 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
13d faster than avg
Panel avg: 122d · This submission: 109d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KWD Device Classification - Class 2, Special Controls

Product Code KWD Prosthesis, Toe, Hemi-, Phalangeal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3730
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - KWD Prosthesis, Toe, Hemi-, Phalangeal

All 38
Devices cleared under the same product code (KWD) and FDA review panel - the closest regulatory comparables to K861983.
FUTURA BIOMEDICAL METAL HEMI TOE IMPLANT
K971047 · Nexa Orthopedics, Inc. · Jun 1997
TOWNLEY GREAT TOE JOINT
K911378 · Biopro, Inc. · Nov 1991
SWANSON TITANIUM GREAT TOE IMPLANT
K864492 · Dow Corning Wright · Apr 1987
IMPLANT, H.P. CONDYLAR
K781870 · Dow Corning Corp. Healthcare Industries Materials · Feb 1979